申请人:Gruenenthal GmbH
公开号:US06013647A1
公开(公告)日:2000-01-11
This invention relates to new benzoxazinedione derivatives corresponding to the formula I: ##STR1## wherein R.sup.1 =H or carboxyalkyl, R.sup.2 =H, alkyl or phenyl, and R.sup.3 represents different acid groups derived from amino acids, dipeptides and hydrazones or conjugates thereof with active ingredients, e.g. antibiotics. The compounds may be present as free acids, in the form of their salts or as readily cleavable esters. The compounds according to the invention constitute heterocyclically protected catechol derivatives and are effective as siderophores against gram-negative bacterial strains, particularly against Pseudomonads and strains of E. coli and Salmonella. In the form of their conjugates with active ingredients, e.g. antibiotics (as "siderophore-antibiotic conjugates"), they can transport the latter into bacterial cells and can improve or extend the antibacterial effect thereof, sometimes even in relation to bacterial strains which are resistant to other .beta.-lactams. In addition, said compounds, as potential prodrug forms for iron chelating agents, are suitable for use against diseases which are caused by a disorder of the iron metabolism. The invention can be employed in pharmaceutical research and in the pharmaceutical industry, and in agriculture.
该发明涉及与以下式I对应的新苯并噁唑二酮衍生物:##STR1## 其中R.sup.1=H或羧基烷基,R.sup.2=H、烷基或苯基,而R.sup.3代表源自氨基酸、二肽和醛腙或其与活性成分(如抗生素)的结合物的不同酸基。这些化合物可以以游离酸的形式存在,也可以以其盐的形式或易于水解的酯的形式存在。根据本发明的化合物构成了杂环保护的邻苯二酚衍生物,对革兰氏阴性细菌株,特别是对铜绿假单胞菌和大肠杆菌和沙门氏菌株具有有效作用。作为与活性成分(例如抗生素)结合物的形式(如“铁载体-抗生素结合物”),它们可以将后者运送到细菌细胞内,并可以改善或延长其抗菌作用,有时甚至相对于对其他β-内酰胺类抗生素具有耐药性的细菌株。此外,所述化合物作为铁螯合剂的潜在前药形式,适用于用于对抗由铁代谢紊乱引起的疾病。该发明可应用于制药研究、制药工业和农业中。